Unihealth Hospitals Ltd

As of March 31, 2026, Unihealth Hospitals Ltd carries a market capitalization of 5.69B, placing it among publicly traded companies globally. Its enterprise value stands at 6.52B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of March 31, 2026, Unihealth Hospitals Ltd has 15.70M shares outstanding.

As of March 31, 2026, Unihealth Hospitals Ltd trades at a trailing price-to-earnings ratio of 21.74. The price-to-sales ratio is 4.26, and the price-to-book ratio stands at 4.13.

As of March 31, 2026, Unihealth Hospitals Ltd trades at an EV/EBITDA multiple of 12.04 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 4.94 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 14.83 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 6.52B versus a market cap of 5.69B, with the gap driven by net debt and cash on the balance sheet.

As of March 31, 2026, Unihealth Hospitals Ltd maintains a current ratio of 5.33, meaning it holds 5.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 16.54, indicating elevated leverage, while an interest coverage ratio of 27.24 demonstrates strong ability to service its debt obligations.

Over the twelve months ended March 31, 2026, Unihealth Hospitals Ltd posted a return on equity (ROE) of 21.62, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 21.57 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 11.75, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 4.00, useful for judging operating efficiency across full business cycles. The company generates approximately 2.20M in revenue per employee across its workforce of 600.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 4.67 indicates how many times Unihealth Hospitals Ltd sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended March 31, 2026, Unihealth Hospitals Ltd recorded 8.46M in income tax expense. That works out to an effective tax rate of 1.83, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 462.94M, leaving 258.30M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 23, 2026, Unihealth Hospitals Ltd's stock has gained approximately 206.43% over the past 52 weeks. The 50-day moving average sits at 648.17, while the 200-day moving average is 508.23.

Over the twelve months ended March 31, 2026, Unihealth Hospitals Ltd generated 1.32B in revenue and converted that into 258.30M in net income, yielding earnings per share of 29.24. EBITDA reached 541.15M, while operating income came in at 436.10M.

As of March 31, 2026, Unihealth Hospitals Ltd holds 104.46M in cash and equivalents against 327.44M in total debt, resulting in a net debt position of 108.62M. Total book value stands at 1.38B, with working capital of 1.27B providing operational flexibility.

Unihealth Hospitals Ltd produced 56.93M in operating cash flow over the twelve months ended March 31, 2026. After subtracting -312.25M in capital expenditures, free cash flow totaled -255.32M - equivalent to -16.47 per share.

Over the twelve months ended March 31, 2026, Unihealth Hospitals Ltd posted a gross margin of 80.38, reflecting its pricing power and cost economics. The operating margin of 33.04 and net profit margin of 19.57 provide insight into operational efficiency.

These figures cover the twelve months ended March 31, 2026. Free cash flow yield is negative at -4.51: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -2.77, meaning Unihealth Hospitals Ltd raised more capital through share issuance and new debt than it returned via dividends and buybacks.

As of March 31, 2026, Unihealth Hospitals Ltd has an Altman Z-Score of 8.18, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.